According to Coloplast's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-09-30 | $0.12 B | 54.27% |
2022-09-30 | $83.67 M | -20.44% |
2021-09-30 | $0.10 B | 13.99% |
2020-09-30 | $92.25 M | -5.91% |
2019-09-30 | $98.05 M | 3.79% |
2018-09-30 | $94.47 M | -5.34% |
2017-09-30 | $99.8 M | -35.95% |
2016-09-30 | $0.15 B | -26.22% |
2015-09-30 | $0.21 B | -22.09% |
2014-09-30 | $0.27 B | -19.94% |
2013-09-30 | $0.33 B | -24.71% |
2012-09-30 | $0.44 B | 30.61% |
2011-09-30 | $0.34 B | 295.51% |
2010-09-30 | $87.06 M | -29.83% |
2009-09-30 | $0.12 B | 238.43% |
2008-09-30 | $36.66 M | -29.43% |
2007-09-30 | $51.95 M | 103.99% |
2006-09-30 | $25.46 M | -85.62% |
2005-09-30 | $0.17 B | 43.87% |
2004-09-30 | $0.12 B | 22.78% |
2003-09-30 | $0.10 B | 118.71% |
2002-09-30 | $45.85 M |